pubmed-article:14743889 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C0014852 | lld:lifeskim |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C0001418 | lld:lifeskim |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C0387583 | lld:lifeskim |
pubmed-article:14743889 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
pubmed-article:14743889 | pubmed:issue | 239 | lld:pubmed |
pubmed-article:14743889 | pubmed:dateCreated | 2004-1-27 | lld:pubmed |
pubmed-article:14743889 | pubmed:abstractText | Various studies suggest that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are promising anticancer agents. Epidemiological studies have found that long-term use of NSAIDs is associated with a reduced incidence of colorectal, gastric and oesophageal cancers, while experimental and clinical studies have demonstrated that treatment with NSAIDs causes a statistically significant reduction in both the number and the size of polyps in familial adenomatous polyposis (FAP) patients. | lld:pubmed |
pubmed-article:14743889 | pubmed:language | eng | lld:pubmed |
pubmed-article:14743889 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14743889 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14743889 | pubmed:issn | 0085-5928 | lld:pubmed |
pubmed-article:14743889 | pubmed:author | pubmed-author:RichelD JDJ | lld:pubmed |
pubmed-article:14743889 | pubmed:author | pubmed-author:RistimäkiAA | lld:pubmed |
pubmed-article:14743889 | pubmed:author | pubmed-author:BuskensC JCJ | lld:pubmed |
pubmed-article:14743889 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:14743889 | pubmed:author | pubmed-author:OfferhausG... | lld:pubmed |
pubmed-article:14743889 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14743889 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14743889 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14743889 | pubmed:pagination | 87-93 | lld:pubmed |
pubmed-article:14743889 | pubmed:dateRevised | 2008-2-13 | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:meshHeading | pubmed-meshheading:14743889... | lld:pubmed |
pubmed-article:14743889 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14743889 | pubmed:articleTitle | Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma. | lld:pubmed |
pubmed-article:14743889 | pubmed:affiliation | Dept. of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. C.J.Buskens@AMC.UVA.NL | lld:pubmed |
pubmed-article:14743889 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14743889 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:14743889 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:14743889 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:14743889 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |